赵万华ZHAO Wanhua长江学者特聘教授Chang Jiang Scholar西安交通大学二级教授Second-Class Professor of Xi’an Jiaotong University全国优秀教师,入选西安交通大学＂腾飞人才计划＂和＂领军人才计划＂。主要从事高速加工工艺、高速...赵万华ZHAO Wanhua长江学者特聘教授Chang Jiang Scholar西安交通大学二级教授Second-Class Professor of Xi’an Jiaotong University全国优秀教师,入选西安交通大学＂腾飞人才计划＂和＂领军人才计划＂。主要从事高速加工工艺、高速机床动力学和机电耦合方面的研究。展开更多
Since the calcium channel blocker （CCB） has become one of the most prescribed agents for antihypertensive monotherapy in the world, this brief review will focus on the recent research and development of the dihydrop...Since the calcium channel blocker （CCB） has become one of the most prescribed agents for antihypertensive monotherapy in the world, this brief review will focus on the recent research and development of the dihydropyridine （DHP） CCB, addressing pharmacological mecha- nisms for the clinical efficacy of the third and fourth generations of the DHP CCBs, especially on their possible central mechanisms underlying lowering blood pressure.展开更多
文摘赵万华ZHAO Wanhua长江学者特聘教授Chang Jiang Scholar西安交通大学二级教授Second-Class Professor of Xi’an Jiaotong University全国优秀教师,入选西安交通大学＂腾飞人才计划＂和＂领军人才计划＂。主要从事高速加工工艺、高速机床动力学和机电耦合方面的研究。
文摘Since the calcium channel blocker （CCB） has become one of the most prescribed agents for antihypertensive monotherapy in the world, this brief review will focus on the recent research and development of the dihydropyridine （DHP） CCB, addressing pharmacological mecha- nisms for the clinical efficacy of the third and fourth generations of the DHP CCBs, especially on their possible central mechanisms underlying lowering blood pressure.
